Episode 222: Antibiotic Resistance

In this episode of Rio Bravo Q Week, Dr. Ariaza is joined by medical students Meher Boparai and Jeremy Pan to discuss the growing global crisis of antibiotic resistance. The conversation begins with a stark reminder that antibiotic resistance is now one of the top threats to modern medicine—on par with nuclear war and pandemics—according to leading infectious disease experts. The hosts walk through five common hospital-acquired pathogens: Staphylococcus aureus (including MRSA), E. coli (especially ESBL-producing strains), Klebsiella pneumoniae (including CRE), Pseudomonas aeruginosa, and Clostridioides difficile. For each, they explain the typical treatment, the emergence of resistance, and the clinical implications when first-line antibiotics fail. The episode emphasizes the importance of antibiotic stewardship, culture-guided therapy, and avoiding unnecessary antibiotic use. A standout moment comes with the discussion of fecal microbiota transplantation (FMT) for recurrent C. diff and the emerging potential of bacteriophage therapy, illustrated by a real-life case from Radiolab. The overarching message is clear: antibiotics are powerful but finite, and their responsible use is critical to preserving their effectiveness for future generations.